Northwire Canada EditionFriday, October 16, 2026
Northwire
⌕
GOLD 4177.30 +0.2% SILVER 57.42 +0.5% COPPER 6.62 +1.0% OIL 95.93 −2.1% PALLADIUM 1130.75 +0.2% BUFF 0.780 +0.0% FEO 0.650 +0.0% LIB 0.720 +0.0% NPR 0.620 +0.0% QZM 0.380 +0.0% BVA 0.760 +0.0% ONAU 0.520 +0.0% FMR 0.225 +0.0% GSVR 0.340 +0.0% PHNM 0.340 +0.0% SLG 5.71 +0.0% CASA 0.060 +0.0% DRY 0.215 +0.0% SOMA 0.560 +0.0% PWRO 0.025 +0.0% OMI 0.250 +0.0% GOLD 4177.30 +0.2% SILVER 57.42 +0.5% COPPER 6.62 +1.0% OIL 95.93 −2.1% PALLADIUM 1130.75 +0.2% BUFF 0.780 +0.0% FEO 0.650 +0.0% LIB 0.720 +0.0% NPR 0.620 +0.0% QZM 0.380 +0.0% BVA 0.760 +0.0% ONAU 0.520 +0.0% FMR 0.225 +0.0% GSVR 0.340 +0.0% PHNM 0.340 +0.0% SLG 5.71 +0.0% CASA 0.060 +0.0% DRY 0.215 +0.0% SOMA 0.560 +0.0% PWRO 0.025 +0.0% OMI 0.250 +0.0%
Financings

PesoRama Announces First Closing of Equity Financing

PESO · Price

Executive Summary

  • PesoRama Inc. completed the first closing of its $5 M equity financing, raising $3.5 M by selling 14 M units at $0.25 each.
  • Each unit includes one common share and one warrant to purchase an additional share at $0.40 for 18 months; accelerated‑warrant provisions were disclosed.
  • Net proceeds are earmarked for store expansion and working capital, with a second tranche expected to close next week pending TSXV approval.

Key Details

  • Units sold: 14 000 000 units @ $0.25 per unit → gross proceeds $3,500,000.
  • Offering size: Total target $5 M; first closing $3.5 M; second tranche pending (expected next week).
  • Unit composition: 1 common share + 1 common‑share purchase warrant.
  • Warrant terms: Exercise price $0.40 per share; exercisable for 18 months from Jan 20 2026 (60 days after closing); acceleration possible if TSXV price ≥ $0.60 VWAP for ten consecutive trading days, with a press‑release notice triggering a new expiry 30 days later.
  • Finder compensation: Cash commission $210 000; issuance of 840 000 non‑transferable finder warrants (each convertible into one unit at $0.25) exercisable until May 21 2027.
  • Use of proceeds: Store expansion and working capital.
  • Regulatory notes: Units issued under the listed issuer financing exemption (LIFE) per NI 45‑106; offering subject to final TSXV approval; no U.S. solicitation.

Notable Quotes

(No direct quotes were included in the release.)

Read the original news release →

More from Pesorama Inc.